封面
市场调查报告书
商品编码
1308720

2030 年预灌封注射器包装市场预测 - 按材料类型、应用、最终用户和地区划分的全球分析

Prefilled Syringe Packaging Market Forecasts to 2030 - Global Analysis By Material Type, Application, End User and By Geography

出版日期: | 出版商: Stratistics Market Research Consulting | 英文 175+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据,全球预充式註射器包装市场在预测期内将以 14% 的复合年增长率增长。

一种称为预填充注射器包装的包装用于在预称重、预填充注射器中储存和输送药物和疫苗。 它的目的是在施用药物和疫苗时方便、准确和安全。 预充式註射器含有预定剂量的药物或疫苗,通常为液体形式,并用防篡改帽或柱塞盖密封。 注射器由与所包装的药物或疫苗相容的材料製成,以确保稳定性并防止污染。

根据美国国家环境健康科学研究所的数据,2017 年,美国有 2400 万人患有自身免疫性疾病。 此外,800 万人体内存在自身抗体——表明他们可能患上自身免疫性疾病的血液分子。

市场动态:

驱动程序

安全需求不断增长

预填充注射器包装通常使用先进的阻隔材料和特殊密封件,以帮助延长药物的保质期。 这最大限度地降低了降解风险并保持了药物的长期稳定性和功效。 预充式註射器还具有防篡改设计,可提供更好的保护。 密封包装有助于防止污染、意外溢出和篡改,从而降低用药错误的风险。 这些因素正在扩大市场。

限制

包装成本高

预充式註射器包装比传统的小瓶包装成本更高。 製造程序、特殊材料和额外的质量控制措施都会增加成本。 此外,预充式註射器的使用可能会受到成本增加的限制,特别是在资源有限的医疗保健系统中。

机会:

新兴国家医疗保健设施的扩张

医疗保健资金不足仍然是新兴经济体的一个问题,对医疗保健的获取和质量产生不利影响,进而影响人口的健康。 过去二十年,全球医疗保健支出占 GDP 的比例估计约为 8% 至近 10%,即每年 8 万亿美元。 这一增长归因于医疗保健成本的上升、治疗选择的扩大以及消费者需求的增加。 不断壮大的中产阶级、不断增长的国内生产总值以及不断增加的政府支出都被认为是推动这一增长的因素。

威胁:

严格监管和有限的可重用性

使用预充式註射器可能需要监管部门的批准并遵守某些法规。 这些规定因国家和地区而异,使问题变得复杂,并可能延迟某些预充注射器形式药物的上市。 此外,预充式註射器不适合重复使用。 这种一次性使用的性质可能会导致更多的医疗废物,甚至可能阻碍市场扩张。

COVID-19 的影响:

随着 COVID-19 的爆发,预计世界各地的免疫接种量将大幅增加。 由于注射器的使用如此频繁,COVID-19 促进了预填充注射器包装的开发。 还研究了具有不同玻璃筒涂层、容量和其他可能影响其对深度冷冻反应的因素的注射器。 2020 年,受 COVID-19 大流行影响,全球预灌封注射器包装市场的销售额出现增长。

酒店业将在预测期内成为最大的行业:

医院领域将主导市场,糖尿病、心血管疾病和癌症患者的住院人数不断增加。 酒店业因其多功能性已成为主要用户。 此外,亚太和非洲发展中国家对医疗基础设施建设的日益关注也有望刺激该行业的增长。

塑料材料领域预计在预测期内復合年增长率最高:

塑料材料领域预计将在预测期内迅速扩张。 由于这些注射器在医疗机构中的采用率越来越高,并且它们具有保护药物免受潮湿的能力,预计该市场在预测期内将会增长。

市场份额最高的地区:

由于医护人员偏爱预充式註射器以减少针刺伤害等因素,预计欧洲将主导预充式註射器包装市场。 此外,多年来,主要市场参与者也加强了在该地区的影响力。 此外,政府鼓励使用一次性医疗用品预防传染病的众多举措以及重要市场参与者的存在预计将支持该地区的增长。

复合年增长率最高的地区:

在预测期内,亚太地区预计将出现最高的复合年增长率。 这是由于快速扩张的经济区的出现和巨大的未开发市场的存在。 此外,由于人口规模大和各种慢性病患病率上升等有利的人口因素,预计该地区的市场将会增长。

主要进展:

2023 年 6 月 - 互联医疗手术和重症监护病房 (ICU) 床位的创新者 Baxter International Inc. 今天宣布在美国推出其新的 ICU 病床 Hillrom Progressa+。 Progressa+ 提供新技术和功能,使护士能够更轻鬆地护理患者,同时支持他们的康復。

2023 年5 月,全球领先的医疗技术公司之一百特国际(Baxter International) 今天宣布,将把其生物製药解决方案(“BPS”) 业务投资给全球最大、最有经验的私募股权投资者之一。已达成最终协议,将全球领先的成长型投资者 Advent International(“Advent”)出售给全球领先的成长型投资者 Warburg Pincus(“Warburg”)。

2023 年2 月,注射剂量创新解决方案的全球领导者West Pharmaceutical Services 扩大了与康宁的突破性合作伙伴关係,推出康宁ValorR 玻璃瓶。并宣布推出其首款产品West Ready Pack(TM ) ),使用采用 SG EZ-fill(R) 技术的康宁 Valor(R) RTU 样品瓶。

报告内容

  • 区域和国家级细分市场的市场份额评估
  • 给新进入者的战略建议
  • 2021 年、2022 年、2023 年、2026 年和 2030 年的综合市场数据
  • 市场趋势(驱动因素、限制因素、机遇、威胁、挑战、投资机会、建议)
  • 根据市场预测提出关键业务领域的战略建议
  • 竞争格局绘製主要共同趋势
  • 公司简介,包括详细的战略、财务状况和最新发展
  • 供应链趋势映射最新技术趋势

免费定制服务:

订阅此报告的客户将获得以下免费自定义选项之一:

  • 公司简介
    • 对其他市场参与者(最多 3 家公司)进行全面分析
    • 主要公司的SWOT分析(最多3家公司)
  • 区域细分
    • 根据客户兴趣对主要国家/地区的市场估计/预测/复合年增长率(注:基于可行性检查)
  • 竞争基准测试
    • 根据产品组合、地域分布和战略联盟对主要参与者进行基准测试

内容

第 1 章执行摘要

第二章前言

  • 执行摘要
  • 利益相关者
  • 调查范围
  • 调查方法
    • 数据挖掘
    • 数据分析
    • 数据验证
    • 研究方法
  • 调查来源
    • 主要研究来源
    • 二手研究来源
    • 先决条件

第三章市场趋势分析

  • 驱动程序
  • 制约因素
  • 机会
  • 威胁
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • 新冠肺炎 (COVID-19) 的影响

第 4 章波特五力分析

  • 供应商的议价能力
  • 买家的议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争公司之间存在敌对关係

第五章预灌封注射器包装全球市场(按材料类型)

  • 玻璃材质
  • 塑料材质

第六章预灌封注射器包装的全球市场(按应用)

  • 疫苗
  • 麻醉剂
  • 抗血栓药物
  • 生物製品
  • 胰岛素製剂

第 7 章预灌封注射器包装的全球市场:按最终用户划分

  • 酒店业
  • 医务室
  • 家庭护理

第 8 章全球预灌封注射器包装市场:按地区划分

  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 意大利
    • 法国
    • 西班牙
    • 欧洲其他地区
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳大利亚
    • 新西兰
    • 韩国
    • 亚太地区其他地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙特阿拉伯
    • 阿拉伯联合酋长国
    • 卡塔尔
    • 南非
    • 其他中东和非洲地区

第 9 章主要进展

  • 合同、合作伙伴关係、联盟和合资企业
  • 收购与合併
  • 推出新产品
  • 业务扩展
  • 其他关键策略

第 10 章公司简介

  • Baxter
  • Becton Dickinson
  • Bespak
  • Bosch Packaging
  • Catalent
  • Ciron Group
  • Corden Pharma
  • Gerresheimer
  • Health Biotech
  • MedXL
  • Nipro
  • Novalek Pharmaceuticals
  • Schott
  • Stevanato Group
  • Troikaa
  • Vetter Pharma
  • West Pharmaceutical Services
  • Ypsomed Holding
Product Code: SMRC23420

According to Stratistics MRC, the Global Prefilled Syringe Packaging Market is growing at a CAGR of 14% during the forecast period. In order to store and deliver medications or vaccines in premeasured and prefilled syringes, a type of packaging known as prefilled syringe packaging is used. When administering medications or vaccines, it is intended to be convenient, accurate, and safe. Prefilled syringes contain a predetermined dosage of medication or a vaccine, usually in liquid form, and are sealed with a tamper-evident cap or plunger cover. The syringes are made of materials that are compatible with the drug or vaccine being packaged to ensure stability and prevent contamination.

According to the National Institute of Environmental Health Science, in 2017, 24 million people had a condition of autoimmune disease in the US. Moreover, 8 million people had auto-antibodies-blood molecules that indicate a person's chance of developing autoimmune disease.

Market Dynamics:

Driver:

Rising need for safety

Advanced barrier materials and specialized seals are frequently found in prefilled syringe packaging, which can aid in extending the shelf life of pharmaceuticals. This minimizes the risk of degradation and ensures that the medication is stable and effective for a longer time. Prefilled syringes also feature a tamper-evident design that adds an extra measure of protection. The risk of medication errors is decreased by the sealed packaging, which helps prevent contamination, unintentional spills, and tampering. As a result of such factors, the market is expanding.

Restraint:

High of packaging

Packaging for prefilled syringes can cost more than packaging for conventional vials. The cost is higher due to the manufacturing procedure, specialized materials, and additional quality control measures. Moreover, prefilled syringe use may be restricted by this increased cost, particularly in healthcare systems with limited resources.

Opportunity:

Expanding healthcare facilities in emerging economies

Inadequate healthcare funding continues to be a problem in emerging nations, which has a negative impact on healthcare access, quality, and ultimately, citizen health. In the past two decades, the share of total global healthcare spending in GDP has increased from about 8% to almost 10%, or an estimated USD 8 trillion annually. This increase is attributed to the rising costs of medical care, the expansion of treatment options, and rising consumer demands. The expansion of the middle class, rising GDP, and increased government spending may all be contributing factors to this growth.

Threat:

Stringent regulations and limited reusability

Prefilled syringe use might necessitate regulatory approval and adherence to particular rules. These rules differ between nations and regions, which complicates matters and might cause a delay in the release of some medications in prefilled syringe form. Additionally, prefilled syringes aren't made to be reused; they're typically only meant to be used once. Due to this single-use nature, more medical waste may be produced, which even inhibits market expansion.

COVID-19 Impact:

An enormous increase in vaccinations is anticipated worldwide as a result of COVID-19 outbreaks. Because syringes are used so frequently, COVID-19 has prompted the development of prefilled syringe packaging. Syringes with different glass barrel coatings, volumes, and other factors that might affect how they react to deep freezing were also studied. The global prefilled syringe packaging market saw an increase in sales as a result of the COVID-19 pandemic's outbreak in 2020.

The hospitals segment is expected to be the largest during the forecast period:

A growing number of patients with diabetes, cardiovascular diseases, and cancer were admitted into hospitals, which led to the hospital segment dominating the market. Because of the variety of applications, hospitals are the main users. A further factor that is anticipated to spur the segment's growth is the growing emphasis on the construction of healthcare infrastructure in developing nations in Asia Pacific and Africa.

The plastic material segment is expected to have the highest CAGR during the forecast period:

The plastic material segment is expected to expand quickly over the forecast period. As a result of these syringes' increased adoption by healthcare facilities and ability to shield drugs from moisture, the market will grow during the anticipated period.

Region with largest share:

Due to factors like the preference of healthcare professionals for prefilled injectable devices to reduce needle-related injuries, Europe is predicted to dominate the prefilled syringes packaging market. Major market players have also bolstered their presence in the area over the years. Additionally, a number of government initiatives to encourage the use of single-use medical supplies to prevent infections, along with the presence of significant market players, are anticipated to support regional growth.

Region with highest CAGR:

Over the forecast period, Asia-Pacific is anticipated to experience the highest CAGR. This is a result of the emergence of rapidly expanding economies and the existence of a sizable untapped market. Additionally, the region's market is anticipated to grow as a result of favorable demographic factors like the large population and rising prevalence of different chronic diseases.

Key players in the market

Some of the key players profiled in the Prefilled Syringe Packaging Market include Baxter, Becton Dickinson, Bespak, Bosch Packaging, Catalent, Ciron Group, Corden Pharma, Gerresheimer, Health Biotech, MedXL, Nipro, Novalek Pharmaceuticals, Schott, Stevanato Group, Troikaa, Vetter Pharma, West Pharmaceutical Services and Ypsomed Holding.

Key Developments:

In June 2023, Baxter International Inc., an innovator in connected beds for med-surg and the intensive care unit (ICU), announced today the U.S. launch of its new Hillrom Progressa+ bed for the ICU. Progressa+ offers new technology and features that help make it easier for nurses to care for patients, while supporting patient recovery.

In May 2023, Baxter International Inc., a leading global medtech company, today announced that it has signed a definitive agreement to divest its BioPharma Solutions ("BPS") business to Advent International ("Advent"), one of the largest and most experienced global private equity investors, and Warburg Pincus, a leading global growth investor.

In February 2023, West Pharmaceutical Services, Inc., a global leader in innovative solutions for injectable drug administration, announces the expansion of its landmark collaboration with Corning Incorporated, that now includes the exclusive distribution rights for Corning Valor® Glass vials and the launch of its first product, West Ready Pack™ with Corning Valor® RTU Vials utilizing SG EZ-fill® technology.

Material Types Covered:

  • Glass Material
  • Plastic Material

Applications Covered:

  • Vaccines
  • Anesthetics
  • Antithrombotic Drugs
  • Biologics
  • Insulin

End Users Covered:

  • Hospitals
  • Clinics
  • Home Care

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026 and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Prefilled Syringe Packaging Market, By Material Type

  • 5.1 Introduction
  • 5.2 Glass Material
  • 5.3 Plastic Material

6 Global Prefilled Syringe Packaging Market, By Application

  • 6.1 Introduction
  • 6.2 Vaccines
  • 6.3 Anesthetics
  • 6.4 Antithrombotic Drugs
  • 6.5 Biologics
  • 6.6 Insulin

7 Global Prefilled Syringe Packaging Market, By End User

  • 7.1 Introduction
  • 7.2 Hospitals
  • 7.3 Clinics
  • 7.4 Home Care

8 Global Prefilled Syringe Packaging Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 Baxter
  • 10.2 Becton Dickinson
  • 10.3 Bespak
  • 10.4 Bosch Packaging
  • 10.5 Catalent
  • 10.6 Ciron Group
  • 10.7 Corden Pharma
  • 10.8 Gerresheimer
  • 10.9 Health Biotech
  • 10.10 MedXL
  • 10.11 Nipro
  • 10.12 Novalek Pharmaceuticals
  • 10.13 Schott
  • 10.14 Stevanato Group
  • 10.15 Troikaa
  • 10.16 Vetter Pharma
  • 10.17 West Pharmaceutical Services
  • 10.18 Ypsomed Holding

List of Tables

  • Table 1 Global Prefilled Syringe Packaging Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Prefilled Syringe Packaging Market Outlook, By Material Type (2021-2030) ($MN)
  • Table 3 Global Prefilled Syringe Packaging Market Outlook, By Glass Material (2021-2030) ($MN)
  • Table 4 Global Prefilled Syringe Packaging Market Outlook, By Plastic Material (2021-2030) ($MN)
  • Table 5 Global Prefilled Syringe Packaging Market Outlook, By Application (2021-2030) ($MN)
  • Table 6 Global Prefilled Syringe Packaging Market Outlook, By Vaccines (2021-2030) ($MN)
  • Table 7 Global Prefilled Syringe Packaging Market Outlook, By Anesthetics (2021-2030) ($MN)
  • Table 8 Global Prefilled Syringe Packaging Market Outlook, By Antithrombotic Drugs (2021-2030) ($MN)
  • Table 9 Global Prefilled Syringe Packaging Market Outlook, By Biologics (2021-2030) ($MN)
  • Table 10 Global Prefilled Syringe Packaging Market Outlook, By Insulin (2021-2030) ($MN)
  • Table 11 Global Prefilled Syringe Packaging Market Outlook, By End User (2021-2030) ($MN)
  • Table 12 Global Prefilled Syringe Packaging Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 13 Global Prefilled Syringe Packaging Market Outlook, By Clinics (2021-2030) ($MN)
  • Table 14 Global Prefilled Syringe Packaging Market Outlook, By Home Care (2021-2030) ($MN)
  • Table 15 North America Prefilled Syringe Packaging Market Outlook, By Country (2021-2030) ($MN)
  • Table 16 North America Prefilled Syringe Packaging Market Outlook, By Material Type (2021-2030) ($MN)
  • Table 17 North America Prefilled Syringe Packaging Market Outlook, By Glass Material (2021-2030) ($MN)
  • Table 18 North America Prefilled Syringe Packaging Market Outlook, By Plastic Material (2021-2030) ($MN)
  • Table 19 North America Prefilled Syringe Packaging Market Outlook, By Application (2021-2030) ($MN)
  • Table 20 North America Prefilled Syringe Packaging Market Outlook, By Vaccines (2021-2030) ($MN)
  • Table 21 North America Prefilled Syringe Packaging Market Outlook, By Anesthetics (2021-2030) ($MN)
  • Table 22 North America Prefilled Syringe Packaging Market Outlook, By Antithrombotic Drugs (2021-2030) ($MN)
  • Table 23 North America Prefilled Syringe Packaging Market Outlook, By Biologics (2021-2030) ($MN)
  • Table 24 North America Prefilled Syringe Packaging Market Outlook, By Insulin (2021-2030) ($MN)
  • Table 25 North America Prefilled Syringe Packaging Market Outlook, By End User (2021-2030) ($MN)
  • Table 26 North America Prefilled Syringe Packaging Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 27 North America Prefilled Syringe Packaging Market Outlook, By Clinics (2021-2030) ($MN)
  • Table 28 North America Prefilled Syringe Packaging Market Outlook, By Home Care (2021-2030) ($MN)
  • Table 29 Europe Prefilled Syringe Packaging Market Outlook, By Country (2021-2030) ($MN)
  • Table 30 Europe Prefilled Syringe Packaging Market Outlook, By Material Type (2021-2030) ($MN)
  • Table 31 Europe Prefilled Syringe Packaging Market Outlook, By Glass Material (2021-2030) ($MN)
  • Table 32 Europe Prefilled Syringe Packaging Market Outlook, By Plastic Material (2021-2030) ($MN)
  • Table 33 Europe Prefilled Syringe Packaging Market Outlook, By Application (2021-2030) ($MN)
  • Table 34 Europe Prefilled Syringe Packaging Market Outlook, By Vaccines (2021-2030) ($MN)
  • Table 35 Europe Prefilled Syringe Packaging Market Outlook, By Anesthetics (2021-2030) ($MN)
  • Table 36 Europe Prefilled Syringe Packaging Market Outlook, By Antithrombotic Drugs (2021-2030) ($MN)
  • Table 37 Europe Prefilled Syringe Packaging Market Outlook, By Biologics (2021-2030) ($MN)
  • Table 38 Europe Prefilled Syringe Packaging Market Outlook, By Insulin (2021-2030) ($MN)
  • Table 39 Europe Prefilled Syringe Packaging Market Outlook, By End User (2021-2030) ($MN)
  • Table 40 Europe Prefilled Syringe Packaging Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 41 Europe Prefilled Syringe Packaging Market Outlook, By Clinics (2021-2030) ($MN)
  • Table 42 Europe Prefilled Syringe Packaging Market Outlook, By Home Care (2021-2030) ($MN)
  • Table 43 Asia Pacific Prefilled Syringe Packaging Market Outlook, By Country (2021-2030) ($MN)
  • Table 44 Asia Pacific Prefilled Syringe Packaging Market Outlook, By Material Type (2021-2030) ($MN)
  • Table 45 Asia Pacific Prefilled Syringe Packaging Market Outlook, By Glass Material (2021-2030) ($MN)
  • Table 46 Asia Pacific Prefilled Syringe Packaging Market Outlook, By Plastic Material (2021-2030) ($MN)
  • Table 47 Asia Pacific Prefilled Syringe Packaging Market Outlook, By Application (2021-2030) ($MN)
  • Table 48 Asia Pacific Prefilled Syringe Packaging Market Outlook, By Vaccines (2021-2030) ($MN)
  • Table 49 Asia Pacific Prefilled Syringe Packaging Market Outlook, By Anesthetics (2021-2030) ($MN)
  • Table 50 Asia Pacific Prefilled Syringe Packaging Market Outlook, By Antithrombotic Drugs (2021-2030) ($MN)
  • Table 51 Asia Pacific Prefilled Syringe Packaging Market Outlook, By Biologics (2021-2030) ($MN)
  • Table 52 Asia Pacific Prefilled Syringe Packaging Market Outlook, By Insulin (2021-2030) ($MN)
  • Table 53 Asia Pacific Prefilled Syringe Packaging Market Outlook, By End User (2021-2030) ($MN)
  • Table 54 Asia Pacific Prefilled Syringe Packaging Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 55 Asia Pacific Prefilled Syringe Packaging Market Outlook, By Clinics (2021-2030) ($MN)
  • Table 56 Asia Pacific Prefilled Syringe Packaging Market Outlook, By Home Care (2021-2030) ($MN)
  • Table 57 South America Prefilled Syringe Packaging Market Outlook, By Country (2021-2030) ($MN)
  • Table 58 South America Prefilled Syringe Packaging Market Outlook, By Material Type (2021-2030) ($MN)
  • Table 59 South America Prefilled Syringe Packaging Market Outlook, By Glass Material (2021-2030) ($MN)
  • Table 60 South America Prefilled Syringe Packaging Market Outlook, By Plastic Material (2021-2030) ($MN)
  • Table 61 South America Prefilled Syringe Packaging Market Outlook, By Application (2021-2030) ($MN)
  • Table 62 South America Prefilled Syringe Packaging Market Outlook, By Vaccines (2021-2030) ($MN)
  • Table 63 South America Prefilled Syringe Packaging Market Outlook, By Anesthetics (2021-2030) ($MN)
  • Table 64 South America Prefilled Syringe Packaging Market Outlook, By Antithrombotic Drugs (2021-2030) ($MN)
  • Table 65 South America Prefilled Syringe Packaging Market Outlook, By Biologics (2021-2030) ($MN)
  • Table 66 South America Prefilled Syringe Packaging Market Outlook, By Insulin (2021-2030) ($MN)
  • Table 67 South America Prefilled Syringe Packaging Market Outlook, By End User (2021-2030) ($MN)
  • Table 68 South America Prefilled Syringe Packaging Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 69 South America Prefilled Syringe Packaging Market Outlook, By Clinics (2021-2030) ($MN)
  • Table 70 South America Prefilled Syringe Packaging Market Outlook, By Home Care (2021-2030) ($MN)
  • Table 71 Middle East & Africa Prefilled Syringe Packaging Market Outlook, By Country (2021-2030) ($MN)
  • Table 72 Middle East & Africa Prefilled Syringe Packaging Market Outlook, By Material Type (2021-2030) ($MN)
  • Table 73 Middle East & Africa Prefilled Syringe Packaging Market Outlook, By Glass Material (2021-2030) ($MN)
  • Table 74 Middle East & Africa Prefilled Syringe Packaging Market Outlook, By Plastic Material (2021-2030) ($MN)
  • Table 75 Middle East & Africa Prefilled Syringe Packaging Market Outlook, By Application (2021-2030) ($MN)
  • Table 76 Middle East & Africa Prefilled Syringe Packaging Market Outlook, By Vaccines (2021-2030) ($MN)
  • Table 77 Middle East & Africa Prefilled Syringe Packaging Market Outlook, By Anesthetics (2021-2030) ($MN)
  • Table 78 Middle East & Africa Prefilled Syringe Packaging Market Outlook, By Antithrombotic Drugs (2021-2030) ($MN)
  • Table 79 Middle East & Africa Prefilled Syringe Packaging Market Outlook, By Biologics (2021-2030) ($MN)
  • Table 80 Middle East & Africa Prefilled Syringe Packaging Market Outlook, By Insulin (2021-2030) ($MN)
  • Table 81 Middle East & Africa Prefilled Syringe Packaging Market Outlook, By End User (2021-2030) ($MN)
  • Table 82 Middle East & Africa Prefilled Syringe Packaging Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 83 Middle East & Africa Prefilled Syringe Packaging Market Outlook, By Clinics (2021-2030) ($MN)
  • Table 84 Middle East & Africa Prefilled Syringe Packaging Market Outlook, By Home Care (2021-2030) ($MN)